Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer
Clinical trial NCT03057743 · TERMINATED
Trial details
- NCT number
- NCT03057743
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2016-04-05
- Primary completion
- 2021-11-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.